Meeting Overview - The first temporary shareholders' meeting of the company for 2025 was held on November 28, 2025, in Changsha, Hunan Province [2] - The meeting was conducted with a combination of on-site and online voting, presided over by Chairman Xie Zilong, and complied with relevant laws and regulations [2][3] Attendance - All 8 current directors attended the meeting, while Director Liu Xiaoen submitted a resignation report on November 27, 2025, due to personal work reasons [3] - All 3 current supervisors and the board secretary attended the meeting, along with some other senior executives [3] Resolutions Passed - Several resolutions were approved, including: - Change of registered capital and amendment of the Articles of Association [4] - Revision of the Rules of Procedure for Shareholders' Meetings [4] - Revision of the Rules of Procedure for Board Meetings [5] - Revision of the Management Measures for Related Transactions [5] - Revision of the Management Measures for External Investments [5] - Revision of the Management System for Raised Funds [5] - Revision of the Management System for External Donations [5] Legal Verification - The meeting was witnessed by Hunan Qiyuan Law Firm, confirming that the meeting's procedures and voting were in compliance with legal requirements [5] Director Resignation and Election - Director Liu Xiaoen's resignation took effect upon delivery of his written report, and it will not affect the board's minimum member count or the company's operations [6][7] - On November 28, 2025, the company held a staff representative meeting to elect Tan Jian as the staff representative director, effective until the end of the current board's term [6][7] New Director Profile - Tan Jian, born in 1977, holds a bachelor's degree in Traditional Chinese Medicine and an MBA. He has been with the company since 2008 and has held various positions, including staff representative supervisor and chairman of the supervisory board [10]
老百姓大药房连锁股份有限公司2025年第一次临时股东大会决议公告